%0 Journal Article
%A Beckmann, Janna
%A Petzold, Moritz
%A Betzler, Felix
%A Ströhle, Andreas
%A Bendau, Antonia
%A Dusemund, Carla
%A Petzold, Gabor C
%A Meisel, Andreas
%A Hoffmann, Sarah
%T Anxiety in Myasthenia Gravis Patients Throughout the COVID-19 Pandemic-Prevalence, Risk Factors, and Association With Vaccination Status.
%J Brain and behavior
%V 15
%N 9
%@ 2162-3279
%C Malden, Mass.
%I Wiley
%M DZNE-2025-01099
%P e70878
%D 2025
%X A high prevalence of COVID-19-related anxiety was observed among the general population during the COVID-19 pandemic. Patients with myasthenia gravis (MG) might be at higher risk for COVID-19-related anxiety due to immunosuppressive therapy in the majority of cases and risk of myasthenic exacerbation in case of an infection. This prospective longitudinal study assessed COVID-19-related anxiety in MG patients over 2 years of the pandemic and its association with MG-specific factors (e.g., disease severity, immunosuppressive medication) and with vaccination status.A three-wave longitudinal online survey was conducted from May 2020 to February 2022, including a total of 648 adult MG patients. Descriptive, univariate, and multivariate analyses were performed to assess COVID-19-related and MG-related anxiety, associated MG-specific factors, and association with vaccination status.COVID-19-related anxiety was frequent, with the most pronounced fear being risk for one's own health (overall 83.9
%K Humans
%K Myasthenia Gravis: psychology
%K Myasthenia Gravis: epidemiology
%K Myasthenia Gravis: drug therapy
%K Myasthenia Gravis: complications
%K COVID-19: psychology
%K COVID-19: epidemiology
%K Female
%K Male
%K Anxiety: epidemiology
%K Anxiety: etiology
%K Anxiety: psychology
%K Middle Aged
%K Risk Factors
%K Prevalence
%K Adult
%K Aged
%K Longitudinal Studies
%K Prospective Studies
%K Vaccination: psychology
%K Vaccination: statistics & numerical data
%K Immunosuppressive Agents: therapeutic use
%K Immunosuppressive Agents: adverse effects
%K SARS-CoV-2
%K autoimmune disease (Other)
%K corona (Other)
%K fear (Other)
%K immunosuppressive treatment (Other)
%K Immunosuppressive Agents (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40958409
%2 pmc:PMC12441002
%R 10.1002/brb3.70878
%U https://pub.dzne.de/record/281352